Chemotherapy Devices Market Size Projected to Hit $21.65 Billion at a 7.31% CAGR by 2032

5 min readMar 21, 2024
Chemotherapy Devices Market

According to the report, Global Chemotherapy Devices market size accrued earnings worth approximately $11.47 Billion in 2023 and is predicted to gain revenue of about $21.65 Billion by 2032, is set to record a CAGR of nearly 7.31% over the period from 2024 to 2032.

Zion Market Research has published a new report titled “Chemotherapy Devices Market by Product (Cannula, Pump, Catheter, and Others) and by End-User (Home Care, Clinics, and Hospitals): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017–2024”.

Request Free Sample

Cancer is caused by uncontrolled and abnormal growth of cells. It can spread to other body parts and is one of the most fatal global diseases. Tobacco is responsible for around 33% of cancer cases worldwide. Poor diet, obesity, excessive alcohol consumption, and low physical activity are responsible for around 10% of cancer cases, exposure to environmental pollutants and ionizing radiation, infections, such as hepatitis B, hepatitis C, Epstein–Barr virus, human papillomavirus infection, and human immunodeficiency virus (HIV).

Cancer can be treated by using several techniques, such as surgery, chemotherapy, radiation therapy, immunotherapy, hormonal therapy, targeted therapy, stem cell therapy, and precision medicine. Chemotherapy involves blocking the progress of cancerous cells. Sometimes, chemotherapy is also used to ease cancerous symptoms by reducing the pain causing tumors. Chemotherapy can be directed orally as a pill, injected into body cavities, veins, muscles, or the spinal fluid. Currently, mostly chemotherapy is directed intravenously though oral chemotherapy medications are gaining wide acceptance across the world. Chemotherapy drugs are normally given in cycles. The cycle contains specific days’ medication followed by a break and recovery time. A chemotherapy cycle typically continues for one to four weeks and is increased. Each chemotherapy course is diverse but usually consists of four to six sessions. According to the Cancer Research UK, cancer was caused almost 9.6 million deaths worldwide in 2018. Most cases of cancer can be averted by following a healthy diet with lots of whole grains, vegetables, fruits, avoiding smoking and too much alcohol, and getting timely vaccination against infectious diseases.

Request Customization

2. Types of Chemotherapy Devices:

  • Infusion Pumps: Explore the role of infusion pumps in delivering precise doses of chemotherapy agents intravenously, highlighting advancements in pump technology for improved accuracy and safety.
  • Catheters and Ports: Discuss the use of central venous catheters and implanted ports for long-term chemotherapy administration, minimizing the need for frequent venipunctures and enhancing patient comfort.
  • Intratumoral Delivery Systems: Cover emerging intratumoral delivery devices designed to directly administer chemotherapy agents into tumor sites, offering localized treatment and reducing systemic side effects.

3. Technological Innovations:

  • Smart Pump Systems: Highlight the integration of smart features in infusion pump systems, including dose calculation algorithms, remote monitoring capabilities, and connectivity with electronic health records (EHR) for enhanced safety and efficiency.
  • Targeted Drug Delivery: Discuss advancements in targeted drug delivery systems, such as nanoparticle-based carriers and drug-eluting implants, enabling precise delivery of chemotherapy agents to tumor cells while minimizing systemic toxicity.
  • Minimally Invasive Techniques: Explore minimally invasive approaches to chemotherapy delivery, such as transarterial chemoembolization (TACE) and intraperitoneal chemotherapy, offering localized treatment options with reduced procedural risks.

4. Market Segmentation by Cancer Type:

  • Solid Tumors: Discuss the utilization of chemotherapy devices in the treatment of solid tumors, including breast cancer, lung cancer, colorectal cancer, and pancreatic cancer, highlighting specific device preferences and treatment protocols for each cancer type.
  • Hematologic Malignancies: Cover the application of chemotherapy devices in the management of hematologic malignancies, such as leukemia, lymphoma, and multiple myeloma, emphasizing the role of infusion pumps and central venous access devices in administering chemotherapy regimens.

5. Regulatory Landscape and Quality Standards:

  • FDA Approval Process: Explain the regulatory pathway for chemotherapy devices in the United States, including premarket approval (PMA) requirements, 510(k) clearance, and post-market surveillance obligations.
  • International Standards: Discuss global regulatory standards and harmonization efforts governing the design, manufacturing, and marketing of chemotherapy devices, ensuring patient safety and product quality across different markets.

6. Competitive Landscape:

  • Key Players: Profile leading companies in the chemotherapy devices market, including manufacturers of infusion pumps, catheters, ports, and intratumoral delivery systems.
  • Market Strategies: Evaluate the strategies adopted by key players to maintain competitiveness, such as product innovation, strategic collaborations, and geographic expansion initiatives.

7. Future Outlook:

  • Personalized Medicine: Explore the role of chemotherapy devices in the era of personalized medicine, integrating genomic profiling, biomarker testing, and targeted therapies to optimize treatment outcomes and minimize adverse effects.
  • Emerging Technologies: Anticipate future advancements in chemotherapy device technologies, including the integration of artificial intelligence (AI), robotics, and biosensors for real-time monitoring and adaptive treatment strategies.
  • Market Expansion: Assess growth opportunities in emerging markets, driven by increasing cancer prevalence, improving healthcare infrastructure, and rising investments in oncology care.

The rising occurrences of multiple cancer types, such as sarcoma, lung cancer, lymphoma, myeloma, and breast cancer, are likely to act as the major growth driver for the chemotherapy devices market globally. Cancer is the second prominent cause of death globally. Furthermore, growing stress on research and development in oncology and the rising demand for precise and biological drug therapies are likely to propel this market in the future. However, unwillingness showed by patients to undergo chemotherapy might limit the chemotherapy devices market globally.

The chemotherapy devices market is segmented into product and end-user. By product, this market is segmented into cannula, pump, catheter, and others. The end-user segment includes home care, clinics, and hospitals.

Europe is likely to be the prominent region in the forecast time period, due to the increasing number of geriatric population, growing government expenditure on chemotherapy procedures through the National Health Service (NHS). The North American region is projected to generate substantial revenue in the future, due to the increasing occurrences of multiple types of cancers. The Asia Pacific chemotherapy devices market is anticipated to grow rapidly in the upcoming years, due to rising awareness regarding cancer diagnosis and treatment.

Buy Now

Some key players of the chemotherapy devices market include -

  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Advanced Chemotherapy Technologies
  • Becton
  • Dickinson and Company
  • Halyard Health
  • Terumo Corporation
  • Fresenius Kabi
  • Moog Inc.
  • Smiths Group PLC
  • Zyno Medical
  • Micrel Medical Devices S.A.

This report segments the global chemotherapy devices market as follows:

Global Chemotherapy Devices Market: By Product

  • Cannula
  • Pump
  • Catheter
  • Others

Global Chemotherapy Devices Market: By End-User

  • Home Care
  • Clinics
  • Hospitals

Global Chemotherapy Devices Market: By Region

  • North AmericaThe U.S.
  • EuropeUKFranceGermany
  • Asia PacificChinaJapanIndia
  • Latin AmericaBrazil
  • The Middle East and Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us — after all — if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States Tel: +49–322 210 92714 USA/Canada Toll-Free №1–855–465–4651 Email: Website: